Introduction
The allogeneic cell therapy market is undergoing significant transformation, driven by advancements in biotechnology, regulatory frameworks, and increasing investments. Allogeneic cell therapies, which involve the use of cells sourced from a donor, offer promising solutions for a variety of diseases, including cancer, autoimmune disorders, and genetic diseases. As this field...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian